Results 261 to 270 of about 75,672 (296)
Some of the next articles are maybe not open access.

Intensity-modulated radiotherapy: Is xerostomia still prevalent?

Current Oncology Reports, 2005
Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT.
Mark S, Chambers   +9 more
openaire   +2 more sources

Intensity-Modulated Radiotherapy – Technology and Clinical Applications

Oncology Research and Treatment, 2002
Intensity-modulated radiotherapy (IMRT) is one of the most important developments in radiooncology of the last years. As an extension of 3D conformal radiotherapy, it provides the possibility of delivering a high radiation dose to the tumor tissue, protecting radiosensible critical organs nearby or even surrounded by the target. This is realized by the
B H, Didinger, W, Schlegel, J, Debus
openaire   +2 more sources

Clinical use of intensity-modulated radiotherapy: part II

The British Journal of Radiology, 2004
Intensity-modulated radiotherapy (IMRT) is a novel conformal radiotherapy technique which is gaining increasing clinical use worldwide. This article aims to summarize the published data pertaining to clinical indications of this therapy for head and neck, central nervous system, and lung tumours. The main indications in head and neck cancer are parotid
M T, Guerrero Urbano, C M, Nutting
openaire   +3 more sources

Conformal radiotherapy, intensity-modulated radiotherapy and image-guided radiotherapy

2008
The aim of radiotherapy is to deliver the desired tumoricidal dose to the intended target as accurately and reliably as possible and avoid unnecessary dose to surrounding normal tissues. This principle was recognized when irradiation was utilized therapeutically over 100 years ago and has been the guiding force for development and refinement of modern ...
openaire   +2 more sources

Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy

International Journal of Radiation Oncology*Biology*Physics, 2006
Xerostomia is a severe complication after radiotherapy for oropharyngeal cancer, as the salivary glands are in close proximity with the primary tumor. Intensity-modulated radiotherapy (IMRT) offers theoretical advantages for normal tissue sparing. A Phase II study was conducted to determine the value of IMRT for salivary output preservation compared ...
Pètra M, Braam   +3 more
openaire   +2 more sources

Intensity‐modulated radiotherapy for early‐stage glottic cancer

Head & Neck, 2015
AbstractBackgroundThe purpose of this study was to report on treatment outcome of intensity‐modulated radiotherapy (IMRT) for early‐stage (cT1–2 cN0 M0) squamous cell carcinoma of the glottis, as compared with patients treated with conventional radiotherapy.MethodsBetween November 2007 and December 2011, 40 consecutive patients were treated with IMRT ...
Berwouts, Dieter   +8 more
openaire   +3 more sources

[Saliva and intensity modulated radiotherapy].

Nederlands tijdschrift voor tandheelkunde, 2008
A dry mouth (xerostomia) is a serious side effect for head and neck cancer patients treated with radiotherapy. The degree of xerostomia is dependent on the dosage in the parotid glands. New, advanced radiation techniques, such as intensity-modulated radiotherapy, can reduce the dosage in the parotid glands, resulting in a significant improvement in the
J M, Roesink   +2 more
openaire   +1 more source

Optimizing the planning of intensity-modulated radiotherapy

Physics in Medicine and Biology, 1994
A method of computing optimized intensity-modulated beam profiles has been further developed and used to generate highly conformal radiotherapy dose distributions. The features of these distributions are shown to be strongly dependent on the tuning built into the algorithm.
openaire   +2 more sources

Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review

Ca-A Cancer Journal for Clinicians, 2022
Deborah C Marshall, Mas   +2 more
exaly  

Home - About - Disclaimer - Privacy